Lixin Qiao

This inventor holds 40 USPTO granted patents and 10 published patent applications, plus 6 CIPO patents and 5 EPO patents, primarily in Kinase Inhibitors. Top assignees: Celgene Avilomics Research, Inc., Celgene Car LLC, The Brigham and Women's Hospital, Inc.. Active years: 2012-2023.

USPTO Granted Patents = 40 (Patent Applications = 10)

% Patents Active = 65.0

CIPO Patents = 6 (Patent Applications = 6)

EPO Patents = 5 (Patent Applications = 9)

Average Co-Inventor Count = 6.2

ph-index = 13

Forward Citations = 725(Granted Patents)

Location History:

Tewksbury, MA (US) (2012 - 2021)
Andover, MA (US) (2012 - 2023)

Company Filing History:

18 out of 44

Celgene Avilomics Research, Inc.

The Brigham and Women's Hospital, Inc.

patents

4. 5 out of 276

Massachusetts Eye and Ear Infirmary

patents

5. 2 out of 5

Avila Therapeutics, Inc.

where one patent can have more than one assignee

Years Active: 2012-2023

Loading Chart...

Areas of Expertise:

Kinase Inhibitors

HCV Protease Inhibitors

Atoh1 Expression

2,4-Disubstituted Pyrimidines

MK2 Inhibitors

Protein Kinase Conjugates

ERK Inhibitors

Bifunctional Synthetic Molecules

2,4-Diaminopyrimidines

Eph B-3 Kinase

Substituted Pyrimidines

Compounds

40 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11542492 - Ligand-directed covalent modification of protein (2023-01-03),

2. 11351168 - 2,4-disubstituted pyrimidines useful as kinase inhibitors (2022-06-07),

3. 11160808 - Compounds that enhance Atoh1 expression (2021-11-02),

4. 11098061 - MK2 inhibitors and uses thereof (2021-08-24),

5. 10828300 - Substituted 2,4-diaminopyrimidines as kinase inhibitors (2020-11-10),

6. 10662195 - Protein kinase conjugates and inhibitors (2020-05-26),

7. 10596172 - 2,4-disubstituted pyrimidines useful as kinase inhibitors (2020-03-24),

8. 10406163 - Compounds that enhance Atoh1 expression (2019-09-10),

9. 10138256 - MK2 inhibitors and uses thereof (2018-11-27),

10. 10010548 - 2,4-disubstituted pyrimidines useful as kinase inhibitors (2018-07-03),

11. 9987276 - Substituted 2,4-diaminopyrimidines as kinase inhibitors (2018-06-05),

12. 9980964 - ERK inhibitors and uses thereof (2018-05-29),

13. 9796700 - ERK inhibitors and uses thereof (2017-10-24),

14. 9694086 - HCV protease inhibitors and uses thereof (2017-07-04),

15. 9676785 - HCV protease inhibitors and uses thereof (2017-06-13),

Title: The Innovative Journey of Inventor Lixin Qiao

Introduction: Lixin Qiao is a pioneering inventor based in Tewksbury, MA (US) known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Lixin Qiao holds several patents in the areas of telecommunications, networking, and software development, showcasing his expertise and creativity in these domains.

Career Highlights: With a career spanning over two decades, Lixin Qiao has worked with leading tech companies, where he has spearheaded research and development projects that have resulted in cutting-edge inventions and solutions.

Collaborations: Throughout his career, Lixin Qiao has collaborated with top researchers, engineers, and developers, both within the United States and internationally, to bring his innovative ideas to life and make a lasting impact on the industry.

Conclusion: Lixin Qiao's passion for innovation, coupled with his technical acumen and collaborative spirit, continues to drive his success as an inventor, inspiring the next generation of innovators to push the boundaries of what is possible in the world of technology.